NCT07485452
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07485452
Title Boosting Osimertinib Blood Brain Barrier Penetration (OSIBBBOOST)
Acronym OSIBBBOOST
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Maastricht University Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD


No variant requirements are available.